Mark Farrah Associates issues its most recent update on large health plan company enrollment and profitability.
Read More
The cost of whole genome sequencing is coming down, but cost, reproducibility, translation and process issues make its routine use for clinical practice unlikely without further refinement and knowledge growth.
Read More
The 2015 Medicare Advantage and Part D Advance Notice and draft Call Letter provide some interesting insights into CMS' views on various topics, as well as reimbursements for those program…
Read More
The annual Pharmacy Benefit Management Institute Specialty Drug Benefit Report highlights trends in this growing category of drugs.
Read More
A new study in the New England Journal of Medicine on treatment options for prostate cancer illustrates the perils of evidence-based medicine.
Read More
The latest survey from the National Business Group on Health and Towers Watson gives further insight on the employer mindset as reform unfolds.
Read More
An article in the Medicare & Medicaid Research Review examines correlates of state-level per capita health spending, finding that income, capacity and share of the elderly are important factors.
Read More
One of the first rigorous studies of the medical home concept, reported in the Journal of the American Medical Association, finds little effect on quality or cost.
Read More
A report from eHealth finds that health insurance on the exchange is costing people substantially more than it did before the implementation of reform.
Read More
Once more into the breach of why there is variability in the cost of care, this time with a report from the National Institute for Health Care Reform, which finds…
Read More